Insulin aspart, recombinant Subcutaneous and Triamcinolone nasal
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Triamcinolone nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: triamcinolone nasal
Brand name: Nasacort Allergy 24HR, Nasacort AQ, Nasacort, Tri-Nasal, Nasacort HFA
Synonyms: Triamcinolone (nasal), Triamcinolone (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Triamcinolone Nasal Spray
- Insulin aspart, recombinant Subcutaneous-Triamcinolone Ointment
- Insulin aspart, recombinant Subcutaneous-Triamcinolone Paste
- Insulin aspart, recombinant Subcutaneous-Triamcinolone topical
- Insulin aspart, recombinant Subcutaneous-Triamcinolone Topical Aerosol
- Insulin aspart, recombinant Subcutaneous-Triamcinolone Topical Aerosol Solution
- Triamcinolone nasal-Insulin degludec
- Triamcinolone nasal-Insulin Degludec (U-100) Prefilled Pens
- Triamcinolone nasal-Insulin Degludec (U-100) Vials
- Triamcinolone nasal-Insulin Degludec (U-200) Prefilled Pens
- Triamcinolone nasal-Insulin degludec and liraglutide
- Triamcinolone nasal-Insulin degludec and liraglutide Subcutaneous